Modestus Obochi

Dr. Modestus Obochi is an accomplished executive with global, diverse, industry-leading experience across pharmaceutical and biotechnology industries, including operational leadership and advisory roles. He has demonstrated successes growing revenues, shareholder value, and managing global P&L in start-up, medium, and large companies. Dr. Obochi has proven fundraising, business development, M&A, and general management skills, building fruitful partnerships with many companies and delivering multimillion-dollar bottom-line growth. Dr. Obochi joins Sernova from Phlow Corp., where he served as Executive Vice President of Strategy and Business Development. In that role, he led the design, development, and execution of corporate strategy and business development plans. Dr. Obochi also managed the due diligence, structuring, and negotiations of all transactions, including licensing deals, product acquisitions, partnerships, M&A, and strategic investments. Prior to his role at Phlow Corp., he held several executive-level commercial and business development roles at leading pharmaceutical companies, including Pfizer, Hospira, and Baxter, as well as at innovative biotechnology companies, including QLT and Pfenex, and has previously consulted for several biotechnology companies. Most notably in these roles, Dr. Obochi helped corporations raise significant capital and successfully structured and closed multiple strategic transactions worth more than $7 billion. Dr. Obochi holds a PhD in immunology from the University of British Columbia, Vancouver, and an MBA from the Beedie School of Business at Simon Fraser University, Vancouver. He has published more than 30 manuscripts, including journal articles and symposia abstracts, and is an inventor on several patents, including one for cell transplantation.